SPEC
Sign in
SpectraCure AB
Save
309.85M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Devices
Industry
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
Similar securities
Based on sector and market capitalization
Report issue